Literature DB >> 8356409

Low serum vitamin D metabolites in women with rheumatoid arthritis.

H Kröger1, I M Penttilä, E M Alhava.   

Abstract

The etiology of osteoporosis associated with rheumatoid arthritis (RA) is unknown. We studied the calcium and vitamin D metabolism in 143 women with RA (mean age 50.7 years). Albumin corrected serum calcium was normal. Serum alkaline phosphatase was increased in 29 percent of cases. Serum vitamin D levels were frequently very low. In 16 percent of the RA patients serum 25(OH)D concentration was below 12.5 nmol/L, which is arbitrarily considered as the limit of vitamin D deficiency osteomalacia. In the winter season 73 percent of the patients had serum 1,25(OH)2D levels below the seasonally adjusted normal range. The lowest values were found in patients with high disease activity. We suggest that there is a disturbance in vitamin D metabolism in RA. This might play a role in osteoporosis associated with RA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356409     DOI: 10.3109/03009749309099266

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  25 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 2.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

3.  Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis.

Authors:  L Yazmalar; L Ediz; M Alpayci; O Hiz; M Toprak; I Tekeoglu
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

Review 4.  Vitamin D in rheumatoid arthritis-towards clinical application.

Authors:  Louisa E Jeffery; Karim Raza; Martin Hewison
Journal:  Nat Rev Rheumatol       Date:  2015-10-13       Impact factor: 20.543

Review 5.  Vitamin D in systemic and organ-specific autoimmune diseases.

Authors:  Nancy Agmon-Levin; Emanuel Theodor; Ramit Maoz Segal; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

6.  25-Hydroxy vitamin D and its relationship with clinical and laboratory parameters in patients with rheumatoid arthritis.

Authors:  F E Abourazzak; S Talbi; N Aradoini; K Berrada; S Keita; T Hazry
Journal:  Clin Rheumatol       Date:  2014-06-13       Impact factor: 2.980

7.  Hyperparathyroidism secondary to hypovitaminosis D in hypoalbuminemic is less intense than in normoalbuminemic patients: a prevalence study in medical inpatients in southern Brazil.

Authors:  Melissa Orlandin Premaor; Gustavo Vasconcelos Alves; Ligia Beatriz Crossetti; Tania Weber Furlanetto
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

8.  Plasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA.

Authors:  Marie Feser; Lezlie A Derber; Kevin D Deane; Dennis C Lezotte; Michael H Weisman; Jane H Buckner; Ted Mikuls; James O'Dell; Peter K Gregersen; V Michael Holers; Jill M Norris
Journal:  J Rheumatol       Date:  2009-03-13       Impact factor: 4.666

Review 9.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

10.  Oxidative stress and calcium-phosphorus levels in Rheumatoid arthritis.

Authors:  S D Walwadkar; A N Suryakar; R V Katkam; K M Kumbar; R D Ankush
Journal:  Indian J Clin Biochem       Date:  2006-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.